The order of cancer-driving mutations—genetic changes—plays an important role in whether tumors in the intestine can develop, ...
New research published in Nature Communications has linked a normal cellular process to an accumulation of DNA mutations in ...
Scientists at UCLA have developed an “off-the-shelf” cell-based immunotherapy that was able to track down and kill pancreatic ...
Archaerhodopsin 3 (AR3) is a microbial proton pump that increases alkalinity inside a cell when exposed to green light.
Immorta Bio today announced the publication of a landmark preclinical study in the Journal of Translational Medicine demonstrating that its novel immunotherapy, SenoVax(TM), dramatically reduces ...
Sickle cell disease is associated with chronic oxidative stress, hemolysis, inflammation, and progressive multi--organ injury, including significant cardiopulmonary complications. Mitochondrial ...
Cancer cachexia, or the wasting syndrome, is a catastrophic condition that causes dramatic and involuntary loss of muscle mass, fat and weight, alongside extreme fatigue, anorexia and anemia in ...
UCLA researchers have developed a CAR-NKT cell therapy that has been more effective than current immunotherapies at fighting ...
PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related manner. MIAMI, FLORIDA / ACCESS Newswire / November ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback